European Archives - Page 535 of 1127 - European Medical Journal

EMJ Hematology 9 [Supplement 5] 2021 feature image

Real World Evidence in Acute Myeloid Leukaemia

In recent years, there has been an increasing appreciation of the role that patient characteristics such as age, gender…

EMJ Hematology 9 [Supplement 5] 2021 feature image

EMJ Hematology 9 [Supplement 5] 2021

In this interview, two experts in the field of acute myeloid leukaemia (AML), Jean-Baptiste Micol, University of Paris-Saclay, France, and Thomas Cluzeau, University Hospital of Nice, France, share their views and debate the current landscape of real-world data in AML research and treatment.

Chumi Khurana

Chumi Khurana on men’s health

Chumi Khurana, Global Head, Prostate Cancer Disease Area Stronghold, Janssen Oncology speaks about her pathway into men’s health and more.

Microbiol & Infect Dis CP

Pasteurella multocida Endocarditis with Septic Arthritis: Case Report and Review of the Literature

There is a paucity of evidence regarding optimal management of Pasteurella spp. endocarditis. The authors report the first case…

A Life Changing Event

A chat with Kris Aves, Metropolitan police officer, about the Westminster Bridge attack in March 2017 and the implication of his injuries.

Machine Blood Pressure Analysis for Patients with Spinal Injury

ACCURATE blood pressure control during surgery following spinal cord injury, could assist in patient recovery, according to a recently published study…

Could Antibiotic Resistance Be Outsmarted by a Computational Approach?

Approximately 700,000 people die each year due to antibiotic resistant bacteria, a statistic that is estimated to rise to millions…

Multidisciplinary Team Approach in Cancer Care: A Review of The Latest Advancements

The management of patients with cancer is complex and requires contribution from a range of healthcare professionals working alongside specialist oncology consultants to address patients’ needs and optimise outcomes.

EMJ Oncology 9 [Supplement 9] 2021

Patients with cancer require meticulous, co-ordinated, and individualised management from oncologists and other healthcare professionals. To meet all the needs of the patient, a multidisciplinary team (MDT) approach is favoured, enabling improved decision making and a better clinical outcome. Interestingly, this approach has been associated with improved overall survival and reduced rates of cancer recurrence compared with non-MDT care.

Direct Oral Anticoagulants, in the treatment of cancer related venous thromboembolism – Patient case studies

In this episode, we have two experts in the field of Direct Oral Anticoagulants for the treatment of cancer-related venous thromboembolisms.